Combination of Galectin-3, CK19 and HBME-1 Immunostaining Improves the Diagnosis of Thyroid Cancer

Oncology Letters - Greece
doi 10.3892/ol.2017.6719
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Diagnostic Value of TROP-2 Expression in Papillary Thyroid Carcinoma and Comparison With HBME-1, Galectin-3 and Cytokeratin 19

Polish Journal of Pathology
MedicineForensic MedicinePathology
2017English

Immunohistochemical Expression of HBME-1, E-Cadherin, and CD56 in the Differential Diagnosis of Thyroid Nodules

Medicina
Medicine
2012English

Serum Galectin-3 in Papillary Thyroid Cancer: Preliminary Results

Endocrine Abstracts
2015English

HBME-1 Expression in Differentiated Thyroid Carcinoma and Its Correlation With the Ultrasonic Manifestation of Thyroid

Oncology Letters
Cancer ResearchOncology
2017English

A Combination of MUC5AC and CA19-9 Improves the Diagnosis of Pancreatic Cancer: A Multicenter Study

American Journal of Gastroenterology
HepatologyGastroenterology
2017English

Serum Levels of Galectin-1, Galectin-3, and Galectin-9 Are Associated With Large Artery Atherosclerotic Stroke

Scientific Reports
Multidisciplinary
2017English

Results of Research of Galectin-3 and Thyroglobulin in Patients With Thyroid Nodules

Grekov's Bulletin of Surgery
2015English

Regulation of Prostate Cancer Progression by Galectin-3

American Journal of Pathology
Forensic MedicinePathology
2009English

Potential Markers for the Diagnosis of Thyroid Cancer

2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy